Cellbxhealth PLC
ANPCF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $1 | $1 |
| % Growth | 0% | -56.5% | 0% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $1 | $1 |
| % Margin | 58.5% | 58.5% | 63.9% | 63.9% |
| R&D Expenses | $0 | $0 | $3 | $3 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5 | $5 | $4 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$3 | -$3 |
| Operating Expenses | $5 | $5 | $4 | $4 |
| Operating Income | -$5 | -$5 | -$3 | -$3 |
| % Margin | -1,215.7% | -1,215.7% | -371.6% | -371.6% |
| Other Income/Exp. Net | -$0 | -$0 | $0 | $0 |
| Pre-Tax Income | -$5 | -$5 | -$3 | -$3 |
| Tax Expense | $0 | $0 | -$0 | -$0 |
| Net Income | -$5 | -$5 | -$3 | -$3 |
| % Margin | -1,164.3% | -1,164.3% | -356.2% | -356.2% |
| EPS | -0.014 | -0.014 | -0.01 | -0.01 |
| % Growth | 0% | -42.6% | 0% | – |
| EPS Diluted | -0.014 | -0.014 | -0.01 | -0.01 |
| Weighted Avg Shares Out | 323 | 323 | 323 | 323 |
| Weighted Avg Shares Out Dil | 323 | 323 | 323 | 323 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$5 | -$5 | -$3 | -$3 |
| % Margin | -1,160.3% | -1,160.3% | -348.1% | -348.1% |